Trichotillomania

A case of response to valproic acid

Edore C. Adewuya, William Zinser, Christopher Thomas

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Trichotillomania (TTM) is a commonly undiagnosed psychiatric illness with known medical complications whose symptoms interfere markedly with daily functioning. Studies regarding the pharmacological treatment of TTM in the adult or pediatric population are sparse, and there is a lack of consensus on drug treatment for TTM. The current trend is to use selective serotonin reuptake inhibitors (SSRIs) on the basis of the current hypothesis that TTM may be a part of the obsessive compulsive spectrum of disorders. However, attempts to substantiate the efficacy of SSRI use in TTM has produced conflicting results. There is increasing evidence that mood stabilizers decrease symptoms of TTM. We present the case of a 10-year-old girl whose lifelong hair-plucking symptoms showed remarkable sustained improvement in response to increased levels of valproic acid. This report, the first with valproic acid, indicates that this drug is potentially effective in significantly reducing symptoms of TTM in a sustained manner. This single case report calls for further investigation regarding the utility of valproic acid in the treatment of TTM.

Original languageEnglish (US)
Pages (from-to)533-536
Number of pages4
JournalJournal of Child and Adolescent Psychopharmacology
Volume18
Issue number5
DOIs
StatePublished - Oct 1 2008

Fingerprint

Trichotillomania
Valproic Acid
Serotonin Uptake Inhibitors
Obsessive-Compulsive Disorder
Pharmaceutical Preparations
Hair
Psychiatry
Consensus
Therapeutics
Pharmacology
Pediatrics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health

Cite this

Trichotillomania : A case of response to valproic acid. / Adewuya, Edore C.; Zinser, William; Thomas, Christopher.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 18, No. 5, 01.10.2008, p. 533-536.

Research output: Contribution to journalArticle

@article{d73207e828014a91866ed5cabfeaec93,
title = "Trichotillomania: A case of response to valproic acid",
abstract = "Trichotillomania (TTM) is a commonly undiagnosed psychiatric illness with known medical complications whose symptoms interfere markedly with daily functioning. Studies regarding the pharmacological treatment of TTM in the adult or pediatric population are sparse, and there is a lack of consensus on drug treatment for TTM. The current trend is to use selective serotonin reuptake inhibitors (SSRIs) on the basis of the current hypothesis that TTM may be a part of the obsessive compulsive spectrum of disorders. However, attempts to substantiate the efficacy of SSRI use in TTM has produced conflicting results. There is increasing evidence that mood stabilizers decrease symptoms of TTM. We present the case of a 10-year-old girl whose lifelong hair-plucking symptoms showed remarkable sustained improvement in response to increased levels of valproic acid. This report, the first with valproic acid, indicates that this drug is potentially effective in significantly reducing symptoms of TTM in a sustained manner. This single case report calls for further investigation regarding the utility of valproic acid in the treatment of TTM.",
author = "Adewuya, {Edore C.} and William Zinser and Christopher Thomas",
year = "2008",
month = "10",
day = "1",
doi = "10.1089/cap.2008.076",
language = "English (US)",
volume = "18",
pages = "533--536",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Trichotillomania

T2 - A case of response to valproic acid

AU - Adewuya, Edore C.

AU - Zinser, William

AU - Thomas, Christopher

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Trichotillomania (TTM) is a commonly undiagnosed psychiatric illness with known medical complications whose symptoms interfere markedly with daily functioning. Studies regarding the pharmacological treatment of TTM in the adult or pediatric population are sparse, and there is a lack of consensus on drug treatment for TTM. The current trend is to use selective serotonin reuptake inhibitors (SSRIs) on the basis of the current hypothesis that TTM may be a part of the obsessive compulsive spectrum of disorders. However, attempts to substantiate the efficacy of SSRI use in TTM has produced conflicting results. There is increasing evidence that mood stabilizers decrease symptoms of TTM. We present the case of a 10-year-old girl whose lifelong hair-plucking symptoms showed remarkable sustained improvement in response to increased levels of valproic acid. This report, the first with valproic acid, indicates that this drug is potentially effective in significantly reducing symptoms of TTM in a sustained manner. This single case report calls for further investigation regarding the utility of valproic acid in the treatment of TTM.

AB - Trichotillomania (TTM) is a commonly undiagnosed psychiatric illness with known medical complications whose symptoms interfere markedly with daily functioning. Studies regarding the pharmacological treatment of TTM in the adult or pediatric population are sparse, and there is a lack of consensus on drug treatment for TTM. The current trend is to use selective serotonin reuptake inhibitors (SSRIs) on the basis of the current hypothesis that TTM may be a part of the obsessive compulsive spectrum of disorders. However, attempts to substantiate the efficacy of SSRI use in TTM has produced conflicting results. There is increasing evidence that mood stabilizers decrease symptoms of TTM. We present the case of a 10-year-old girl whose lifelong hair-plucking symptoms showed remarkable sustained improvement in response to increased levels of valproic acid. This report, the first with valproic acid, indicates that this drug is potentially effective in significantly reducing symptoms of TTM in a sustained manner. This single case report calls for further investigation regarding the utility of valproic acid in the treatment of TTM.

UR - http://www.scopus.com/inward/record.url?scp=54249086627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249086627&partnerID=8YFLogxK

U2 - 10.1089/cap.2008.076

DO - 10.1089/cap.2008.076

M3 - Article

VL - 18

SP - 533

EP - 536

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 5

ER -